personalized medicine
Pathologists See Value Balance Shift Toward Comprehensive Sequencing for Hematologic Cancers
Premium
At the AMP annual meeting last week, speakers at multiple workshops said their field is reaching a tipping point as the clinical utility of NGS further solidifies.
Genomadix, Mayo Clinic Partner on CYP2C19 Testing for Remote Care For Stroke Patients
The partnership is intended to help expand adoption of the company's rapid PCR system in sites that treat stroke patients, including through telemedicine platforms.
Antimicrobial Susceptibility Tech Firm iFast Diagnostics Raises $6.5M
The UK-based company is developing a platform to help determine the best antibiotic treatment for individual patients.
NeoGenomics Wins New York State Approval for Solid Tumor, Lung Cancer NGS Tests
Although the approval is conditional, the company can now offer the tests for physicians and patients in the state.
Velsera, Diagnóstica Longwood Partner for Precision Genomics Medicine in Spain, Portugal
The collaboration will bring together Velsera's clinical genomics analysis software with Diagnóstica Longwood's regional distribution knowledge and network.
Jul 29, 2024
Dec 7, 2023